Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Proinflammatory activation of Kupffer cells is implicated in the effect of high-fat feeding to cause liver insulin resistance. We sought to determine whether reduced endothelial nitric oxide (NO) signaling contributes to the effect of high-fat feeding to increase hepatic inflammatory signaling and if so, whether this effect 1) involves activation of Kupffer cells and 2) is ameliorated by increased NO signaling. RESEARCH DESIGN AND METHODS: Effect of NO/cGMP signaling on hepatic inflammation and on isolated Kupffer cells was examined in C57BL/6 mice, eNos−/− mice, and Vasp−/− mice fed a low-fat or high-fat diet. RESULTS: We show that high-fat feeding induces proinflammatory activation of Kupffer cells in wild-type mice coincident with reduced liver endothelial nitric oxide synthase activity and NO content while, conversely, enhancement of signaling downstream of endogenous NO by phosphodiesterase-5 inhibition protects against high fat–induced inflammation in Kupffer cells. Furthermore, proinflammatory activation of Kupffer cells is evident in eNos−/− mice even on a low-fat diet. Targeted deletion of vasodilator-stimulated phosphoprotein (VASP), a key downstream target of endothelially derived NO, similarly predisposes to hepatic and Kupffer cell inflammation and abrogates the protective effect of NO signaling in both macrophages and hepatocytes studied in a cell culture model. CONCLUSIONS: These results collectively imply a physiological role for endothelial NO to limit obesity-associated inflammation and insulin resistance in hepatocytes and support a model in which Kupffer cell activation during high-fat feeding is dependent on reduced NO signaling. Our findings also identify the NO/VASP pathway as a novel potential target for the treatment of obesity-associated liver insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In health, LSECs regulate anti-inflammatory and antifibrotic signalling by preventing KC and HSC activation via nitric oxide, cGMP and VASP (vasodilator stimulated phosphoprotein).138”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · cited 2×
“Growing evidence suggests that inflammatory signaling pathways mediate insulin resistance induced by nutrient excess in both cultured hepatocytes and in hepatic tissue in vivo (2,4,7,20).”
BackgroundKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · cited 1×
“Hepatic triglyceride content was measured in liver lysates as previously described (18).”
MethodIKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847 · cited 2×
“Because Kupffer cells play an important role in the development of hepatic insulin resistance during high-fat feeding (2,20), we next sought to investigate the time course of Kupffer cell activation during high-fat feeding in normal mice using a validated Kupffer cell isolation method (3).”
MethodStructural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review
Braet, F., & Wisse, E. (2002) · Comparative Hepatology · doi:10.1186/1476-5926-1-1 · Cited by 753 · cited 1×
“The liver is a highly vascularized tissue receiving 20% of cardiac output, and hepatic sinusoidal endothelial cells make up 50% of nonparenchymal cells of the liver (8,9).”
BackgroundFundamentals of Endothelial Function for the Clinical Cardiologist
Verma, S., & Anderson, T. J. (2002) · Circulation · doi:10.1161/hc0502.104540 · Cited by 602
Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity
Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., & Schwartz, M. W. (2007) · Circulation Research · doi:10.1161/circresaha.106.142851 · Cited by 584 · cited 3×
“During the final 2 weeks of the highfat feeding protocol, mice on each diet received daily oral administration of either vehicle or the phosphodiesterase-5 (PDE-5) inhibitor sildenafil at a dose (30 mg/kg per day) that did not affect weight gain on either diet compared with the vehicle control group (15).”
MethodInfluentialSelf-citationDuplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.342 · Cited by 533 · cited 1×
“Previous investigators have demonstrated that deletion of eNOS results in increased systemic insulin resistance (21,27).”
BackgroundHuang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520 · cited 1×
“Depletion of Kupffer cells using gadolinium chloride attenuated the development of hepatic steatosis and hepatic insulin resistance, suggesting an important early role for Kupffer cells in diet-induced alterations in hepatic insulin resistance (1).”
Background
Cited by
Items 101–138 of 138
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
Kotlyarov, S. N. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.597 · Cited by 6
Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease
Kotsos, D., & Τζιόμαλος, Κ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033049 · Cited by 7
Joseph, A., Parvathy, S., Varma, K. K., & Nandakumar, A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00694-y · Cited by 5
Sowton, A. P., Holzner, L. M. W., Krause, F. N., Baxter, R. M., Mocciaro, G., Krzyzanska, D., Minnion, M., O’Brien, K. A., Harrop, M. C., Darwin, P. M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2024 · Cited by 7
“In liver, NO (generated by eNOS ) inhibits activation of proin fl ammatory Kupffer cells, a response characteristic of MASLD pathogenesis (41).”
The VASP Road to NAFLD: A Macrophage Detour
Lastra, G., Manrique, C. M., Jia, G., & Sowers, J. R. (2015) · Diabetes · doi:10.2337/db15-0551 · Cited by 4
“Both the global deletion of eNOS or VASP recapitulate these findings without need for a high-fat–diet challenge, thus highlighting the role of diminished NO and VASP activation in the pathogenesis of fatty liver (15).”
BackgroundTateya, S., Rizzo, N. O., Cheng, A. M., Dick, B. P., Lee, W. J., Kim, M. L., O’Brien, K. D., Morton, G. J., Schwartz, M. W., & Kim, F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215601 · Cited by 5
Self-citationWu, Y., Le, W., Zhang, H., & Zhu, Y. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123879 · Cited by 4
Loughran, P., Xu, L., & Billiar, T. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00058-8 · Cited by 3
Murine diabetic models for dengue virus infection
Liu, X., Liu, Y., Wu, H., He, Z., Li, Z., Qin, Z., Yu, J., Zhu, L., Wu, Q., Xiao, W., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28088 · Cited by 3
Chao, K., Chen, S., Chang, C., Lee, Y., Wang, C., & Chang, J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600753 · Cited by 4
Wilson, R. B., Chen, Y. J., Zhang, R., Maini, S., Andrews, T. S., Wang, R., & Borradaile, N. M. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00276.2023 · Cited by 2
Chen, T., Grefhorst, A., & Holleboom, A. G. (2025) · Lipidology · doi:10.3390/lipidology2020010 · Cited by 2
AL-Biati, B. S. H. A., Ismail, S. H., Sahib, A. S., Kazaal, F., & M.Alrubaie, S. (2014) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20141217 · Cited by 2
Salami, A. T., Orji, J. C., Akpamu, U., Iyiola, T. O., & Olaleye, S. B. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04467-z · Cited by 1
“NO from eNOS could be protective through the inhibition of inflammatory activation of Kupffer cells [92] and enhancement of mitochondrial fatty acid β-oxidation [93].”
Oteyola, A. O., de Oliveira, I. M. S., de Almeida, J. M., Cardoso, L. C., Paula, T. D. M. D. E., Nogueira, J. M., Carvalho, J. C. D. S., Nogueira, H. M., Porto, B. L. S., Mota, A. P. L., et al. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108836 · Cited by 1
Tan, W., Deng, J., Qi, L., & Tan, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1467950 · Cited by 2
Bahadoran, Z., Azizi, F., & Ghasemi, A. (2025) · Nitric Oxide · doi:10.1016/j.niox.2025.05.004 · Cited by 1
Macrophage mechanobiology: from sensing to disease
D’Ambrosio, M., Warasnhe, K., Eldesouki, M. H., Joshi, V., Beyder, A., & Cipriani, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1812501 · Cited by 5
“…of NO leading to HSCs activation that releases chemokines such as macrophage colony-stimulating factor (CSF1) and monocyte chemoattractant protein-1 (MCP1), which promote macrophage adhesion, migration, and cytokine secretion altering the balance of liver in fl ammation and injury (140, 141).”
Yazıhan, N., & Akdaş, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35358-2_8 · Cited by 1
TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver diseasePreprint
Jung, E., Baek, E. B., Hong, E.-J., Kang, J. H., Park, S., Hong, E., Cho, Y., Ko, J., Won, Y., & Kwon, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.526192 · Cited by 1
Investigating the Synergistic effect of Leucine-Metformin-Sildenafil on Nonalcoholic Steatohepatitis
Fu, L. (2015) · Digital Archive @ GSU · doi:10.57709/7443898
Short title: A Role of VASP on hepatic fatty acid oxidation
Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan‐Stevenson, V., Ogimoto, K., Kanter, J. E., Bornfeldt, K., Daum, G., Clowes, A. W., et al. (2013)
Self-citationRoberts, L. D., Ashmore, T., Murray, A. J., & Griffin, J. L. (2016) · Diabetes · doi:10.2337/dbi15-0024
phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
Xue, B., & Zemel, M. B. (2015)
Hong, W. (2013) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000e110
“Several laboratories have also reported the increased expression of pro-inflammatory cytokines in the liver, skeletal muscle and adipose tissue which required between 8 and 16 weeks, respectively after starting HFD feeding [34-36].”
BackgroundNovel Role of CD47 in Obesity-Associated Metabolic Dysfunctions
Norman‐Burgdolf, H. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.491
“Subsequent studies confirmed elevated cGMP/PKG activity is protective against the development of obesity, reduces obesity-associated inflammation, and promotes mitochondrial biogenesis in skeletal muscle (9, 93, 185, 214, 260).”
BackgroundLee, W. J., & Kim, F. (2016) · Diabetes · doi:10.2337/dbi15-0030
“In support of this idea, animal data and observations from clinical studies suggest improvement in fasting glucose levels in type 2 diabetes following treatment with sildenafil (3).”
ResultSelf-citationSome Virological Studies on Rift Valley Fever Virus in Camels
Kamal, S. A. (2018) · Journal of Vaccines Immunology and Immunopathology · doi:10.29011/2575-789x.000126
Cunningham, R. P. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81558
Liver Sinusoidal Cells in alcohol-associated liver disease
Iwakiri, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00013-9
The liver sinusoid in chronic liver disease: NAFLD and NASH
Kwanten, W. J., & Francque, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00012-7
The Role of Liver Sinusoidal Endothelial Cells in NAFLD Disease
黄, 玥. (2024) · Pharmacy Information · doi:10.12677/pi.2024.133025
Hormetic association between sodium nitrate and liver enzymes: a study in female and male rats
Zeinodini, R., Jeddi, S., Kashfi, K., & Ghasemi, A. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf104
Angeli, E., Ribas, L., Storani, G., Simonetto, C., Matiller, V., Ortega, H. H., & Hein, G. J. (2026) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2026.107002
Role of autophagy in liver sinusoidal endothelial cells on nonalcoholic steatohepatitis
Hammoutène, A. (2018) · theses.fr (ABES) · doi:10.70675/bce7a140z3574z43dbza40ez1cd3403ed525
LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome
Nurtazina, A., Koss, V. A., Voitsekhovskiy, I., Toishimanov, M., Dautov, D., Karibayev, K., Shender, V. О., & Arapidi, G. P. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16080425
“…(VASP [27], C1R [28], CALD1 [30], LTBP1 [31], LASP1 [32], PDLIM1 [33], SRGN [34], TUBB1 [40–42], and QSOX1 [43,44]), coagulation-related shifts (HCII [35–37] and TUBB1 [40–42]), and tissue remodeling (CALD1 [30], LTBP1 [31], LASP1 [32], PDLIM1 [33], PARVB [38,39], TUBB1 [40–42], and QSOX1 [43,44]).”
InfluentialChaurasiya, V., Pham, D. D., & Olkkonen, V. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1957205
“While various approaches to replenish NO supply have yielded promising results concerning metabolic health (52 – 54), the speci fi c impacts of adipose tissue endothelial NO production have only been studied to a limited extent.”
BindingDB (2016) · UC San Diego · doi:10.7270/q28p624w
Metadata
- Authors
- Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan-Stevenson, V., Daum, G., Clowes, A. W., Morton, G. J., Schwartz, M. W., & Kim, F.
- Affiliations
- University of Washington (US)
- Department of Medicine, University of Washington, Seattle, Washington
- Corresponding author
- Kim, Francis
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-10-17
- Volume
- 60
- Issue
- 11
- Pages
- 2792-2801
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3198085
- OpenAlex
- W2152816919
- Cited by
- 138
- References
- 35
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Manpei Suzuki Diabetes Foundation
- National Institutes of Health (5r01dk073878-05)
- National Heart, Lung, and Blood Institute (HL-52459, R01HL052459, R37HL052459)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-083042, DK052989, R01DK052989, R01-DK-073878, DK-073878, R01DK090320, R01DK083042)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- endothelial nitric oxide, Kupffer cell activation, hepatic insulin resistance, high-fat diet, cGMP signaling, VASP, nitric oxide synthase, phosphodiesterase-5 inhibition, liver inflammation, obesity
- MeSH terms
- Vasodilator-Stimulated Phosphoprotein, Animals, Cells, Cultured, Dietary Fats, Gene Expression Regulation, Cyclic GMP, Hepatitis, Insulin Resistance, Kupffer Cells, Liver, Male, Mice, Inbred C57BL, Microfilament Proteins, Nitric Oxide, Obesity, Phosphoproteins, Signal Transduction, Cell Adhesion Molecules, Cytokines, Mice, Knockout, Endothelial Cells, Mice, Nitric Oxide Synthase Type III, Phosphodiesterase 5 Inhibitors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.